EOLS
Price:
$14.71
Market Cap:
$928.12M
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-02-08
Stock Exchange
NASDAQ
Ticker
EOLS
According to Evolus, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -16.34. This represents a change of 27.72% compared to the average of -12.79 of the last 4 quarters.
The mean historical PE Ratio of Evolus, Inc. over the last ten years is -12.34. The current -16.34 PE Ratio has changed 13.14% with respect to the historical average. Over the past ten years (40 quarters), EOLS's PE Ratio was at its highest in in the March 2021 quarter at 18.82. The PE Ratio was at its lowest in in the June 2017 quarter at -23.28.
Average
-12.34
Median
-6.87
Minimum
-60.56
Maximum
-0.70
Discovering the peaks and valleys of Evolus, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 895.41%
Maximum Annual PE Ratio = -0.70
Minimum Annual Increase = -89.77%
Minimum Annual PE Ratio = -60.56
Year | PE Ratio | Change |
---|---|---|
2023 | -9.72 | 71.72% |
2022 | -5.66 | -18.26% |
2021 | -6.92 | 895.41% |
2020 | -0.70 | -81.78% |
2019 | -3.82 | -38.40% |
2018 | -6.20 | -89.77% |
2017 | -60.56 | 468.32% |
2016 | -10.66 | 55.06% |
The current PE Ratio of Evolus, Inc. (EOLS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.43
5-year avg
-5.36
10-year avg
-12.34
Evolus, Inc.’s PE Ratio is less than Collegium Pharmaceutical, Inc. (12.07), less than Phibro Animal Health Corporation (324.20), less than ANI Pharmaceuticals, Inc. (43.28), less than Procaps Group S.A. (4.69), less than Silver Spike Investment Corp. (14.29), less than Eagle Pharmaceuticals, Inc. (5.10), less than Deciphera Pharmaceuticals, Inc. (-11.74), less than Prestige Consumer Healthcare Inc. (18.08), less than Pacira BioSciences, Inc. (10.06), greater than Intra-Cellular Therapies, Inc. (-90.48), less than Alkermes plc (15.66), less than Amphastar Pharmaceuticals, Inc. (13.33), less than Ascend Wellness Holdings, Inc. (-2.78), less than Incannex Healthcare Limited (-1.34), less than Supernus Pharmaceuticals, Inc. (355.12),
Company | PE Ratio | Market cap |
---|---|---|
12.07 | $1.20B | |
324.20 | $788.20M | |
43.28 | $1.27B | |
4.69 | $218.91M | |
14.29 | $71.22M | |
5.10 | $55.19M | |
-11.74 | $2.21B | |
18.08 | $3.68B | |
10.06 | $638.86M | |
-90.48 | $7.77B | |
15.66 | $4.42B | |
13.33 | $2.21B | |
-2.78 | $197.13M | |
-1.34 | $29.29M | |
355.12 | $1.86B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evolus, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Evolus, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Evolus, Inc.'s PE Ratio?
How is the PE Ratio calculated for Evolus, Inc. (EOLS)?
What is the highest PE Ratio for Evolus, Inc. (EOLS)?
What is the 3-year average PE Ratio for Evolus, Inc. (EOLS)?
What is the 5-year average PE Ratio for Evolus, Inc. (EOLS)?
How does the current PE Ratio for Evolus, Inc. (EOLS) compare to its historical average?